These data are generated from a global clinical development plan which was designed a long time before the new medicine's submission for reimbursement.
These results may be useful in the selection of clade C vaccine antigens that could potentially be used in clinical development studies designed to repeat the RV144 prime/boost immunization regimen.
DFN-02 — sumatriptan 10 mg plus 0.20% 1-O-n-Dodecyl-β-D-Maltopyranoside (DDM), a permeation-enhancing excipient — is a new intranasal migraine treatment under clinical development that is designed to overcome many of the limitations to currently available acute medications.
Based on a putative binding mode of quizartinib (AC220, 1), a potent FMS-like tyrosine kinase 3 (FLT3) inhibitor in Phase III clinical development, we have designed de novo a simpler aminopyridine-based hinge binding motif.
The result should be more efficient and scientifically founded clinical development strategies for rationally designed target-based therapeutic agents.
This article reviews the progress of the past three decades in regard to the preclinical discovery and attempted clinical development of antioxidant drugs designed to inhibit free radical-induced LP and its neurotoxic consequences via different mechanisms including the O2·− scavenger superoxide dismutase and the lipid peroxidation inhibitor tirilazad.
An ongoing clinical development program (SUMMIT) is designed to further explore the combination of PDT therapy plus ranibizumab and to provide insight into the efficacy, safety, treatment practice, and health economics of this combination therapy.
Novel approaches for clinical development and trial design could have a key role in overcoming some of these challenges by improving efficiency and reducing attrition rates.
In this paper, we outline the potential pathways and challenges in various aspects of cardiovascular safety evaluation in type 2 diabetes clinical development, including study design, populations, and endpoints.
The clinical development program in NVAF was designed to examine the efficacy and safety of apixaban for the prevention of stroke in this largely elderly patient population.
This knowledge was reflected in the clinical development of T-DM1, originally designed to have a valine citrulline dipeptide linker but was instead produced with a non-cleavable thioether linker [ 128].
